Editorial
 NEW DRUGS WITHOUT TRIALS!   
 Wednesday, August 09, 2017 
 The Union health ministry is reported to be considering to do away with the mandatory three phase clinical trials before launching new drugs if they have proved their safety and efficacy in developed countries. 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]Shuttle Pharma, POLA Pharma enter pact to license US rights for doranidazole
17:40  [IST]J&J partners with CSIR-IMTECH to develop innovative new tuberculosis treatments
17:00  [IST]Bristol-Myers Squibb reports positive results from CheckMate -214 phase 3 study of Opdivo in combo with Yervoy to treat advanced/metastatic RCC
16:40  [IST]Sri Ramachandra University, Chennai to start two new para-medical courses in this academic year
16:00  [IST]EnvoyHealth signs co-marketing partnership with PharMedQuest for ARC medical benefit drug management platform
15:45  [IST]ISF College of Pharmacy, Moga launches risk screening project
more news >>
TOP NEWS
08:00  [IST]ICMR to launch programme to develop/scale up innovative, cost effective & sustainable models to engage private sector for TB elimination
08:00  [IST]Pharmexcil urges African lawmakers to recognise Indian Pharmacopoeia
08:00  [IST]Hetero to supply swine flu drug to Gujarat govt to avert any possibility of stock outs in near future
08:00  [IST]ICMR and George Institute to focus on using data and research to shape policy and programmes for women’s health
08:00  [IST]Experts in Indian traditional medicines want inclusion of cosmetics into TKDL
08:00  [IST]AICTE alerts public and warns universities conducting technical & pharmacy programmes without approval
more news >>
YESTERDAY'S NEWS
18:00  [IST]Ionis Pharma to advance inotersen and IONIS-FB-L Rx drugs independently
17:30  [IST]Zydus settles Canasa patent litigation with Aptalis
17:15  [IST]Ahmedabad based LM College of Pharmacy to receive Rs. 10 crore grant to set up Atal Incubation Center
17:00  [IST]US FDA warns of potential contamination in multiple brands of drugs, dietary supplements
16:45  [IST]Strides Shasun net declines sharply by 86% in Q1
16:30  [IST]Laurus Labs net jumps by 52% in Q1
more news >>
INTERVIEW  
New stent pricing to help improve top and bottom lines
Swaminathan Jayaraman, Chairman and Managing Director,
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the Union Health Ministry’s proposal to amend DC Rules to make only registered pharmacists eligible for wholesale licenses justified ?
 
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
IPJPI_150x60en_2017
CPhI-WWW-150x60-stat-v1
IPJPI_150x60en_2017
chemspec2017
cphikorea_150x60_k
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |